|
|
|
Accreditation Information
Listen to Real Audio Round Table Discussion
Part 2: The Treatment of Alcohol Withdrawal
Program Faculty
Robert Malcolm, M.D., Professor of Psychiatry, Family Medicine
and Pediatrics, Medical University of South Carolina
Associate Dean for Continuing Medical Education
Member of the Faculty of the Center for Drug and Alcohol Programs at
the Medical University of South Carolina, Charleston, SC
Jack Gorman, M.D., Professor of Psychiatry and Vice-Chair for
Academic Affairs, Mount Sinai School of Medicine, New York, NY
Hugh Myrick, M.D., Assistant Professor of Psychiatry at
the Medical University of South Carolina in Charleston, SC and also at
the Ralph H. Johnson V.A. Medical Center in Charleston, SC.
Sponsor:
School of Medicine, Virginia Commonwealth University,
Medical College of Virginia Campus (VCU), Richmond, VA
Production services for this monograph:
KSP Communications,
140 Sherman St, 3rd Floor, Fairfield, CT 06824, (203) 259-2279.
Website Design and Development:
Chris Stephens
Jeanne Schlesinger, M.Ed.
Systems Requirements
- 233MHz Intel Pentium II processor
- 64MB of RAM
- 28.8Kbps modem (audio only)
- 16-bit sound card and speakers
- 65,000-color video display card set to display at 800x600 (video)
- Windows 98, Windows 2000, Windows ME, Windows NT 4.0 with Service Pack 4 or later, Windows XP
- IE 5.0 or later
- Add Macromedia Flash player if not already installed
- Add Real player if not already installed
- Add Adobe Acrobat reader if not already installed
Faculty Disclosure
In compliance with the Standards for Commercial Support of
Continuing Medical Education (ACCME), the following faculty report
these relationships:
Robert Malcolm, M.D.: Research support: GlaxoSmithKline and Sanofi.
Consultant: GlaxoSmithKline, Cephalon, and Sanofi.
Jack Gorman, M.D.: Research support: The National Institute of Mental
Health, National Alliance for Research on Schizophrenia and
Depression and Eli Lilly. Consultant and speaker: GlaxoSmithKline,
Eli Lilly, Pfizer, Forest, Janssen, Lundbeck, Sanofi-Synthelabo, Aventis,
Cephalon, USB Pharma, Solvay, AstraZeneca, Wyeth-Ayerst, and
Novartis.
Hugh Myrick, M.D.: Speaker: Pfizer, Abbott, and Forest.
Accreditation and Educational Credit
The School of Medicine, Virginia Commonwealth University, Medical College of Virginia Campus (VCU) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for
physicians.
VCU designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
This educational activity was planned in
accordance with Accreditation Council for Continuing Medical Education (ACCME) Essentials and Standards.
Statement of Educational Need
This activity is designed to respond to the needs of psychiatrists
and other physicians who treat patients undergoing alcohol and/or
benzodiazepine withdrawal by updating their knowledge of GABAenhancing
agents, which are emerging as potentially important
agents in the treatment of alcohol dependence and other substance
abuse disorders.
This activity is designed to respond to the needs of psychiatrists and other physicians who treat patients with anxiety and other neuro-psychiatric disorders by updating their knowledge of GABA-enhancing agents, which are emerging as potentially important agents in the
treatment of these disorders.
Educational Objectives
After reading this monograph, listening to the audio CD, and completing the post-test, the participant should be able to:
- Better understand the roles of GABA and glutamate in the central
nervous system
- Better understand the neuropsychiatric effects of acute
alcohol withdrawal
- Describe the drawbacks of benzodiazepines in the treatment of
alcohol withdrawal
- Understand the rationale for using GABAergic anticonvulsants to
treat alcohol and benzodiazepine withdrawal syndromes
- Describe the potential clinical utility of the newer, specific
GABA-enhancing agents
Statement of Educational Method
The educational information is presented online in two separate pages, which cover the same material as the original 8-page written monograph. The original accompanying 30-minute audio CD is available online under the link "Round Table Discussion (Real Audio)"
Statement of Evaluation Instrument
A 10-question multiple-choice post-test is used as the evaluation instrument. An activity evaluation questionnaire will be completed by each participant.
Statement of Intended, or Target, Audience
This activity is intended for, but not limited to: psychiatrists and other physicians who treat patients with alcohol withdrawal syndrome.
Statement of Unlabeled Usage
The information presented in this activity is that of the presenters and
does not necessarily represent the views, and is independent of, Virginia
Commonwealth University and KSP Communications. Specific medicines
discussed in this monograph may not yet be specifically approved and/or
may not be specified to be used as indicated by the speakers. Before pre-scribing
any medication, the physician should review the complete pre-scribing
information, including indications, contraindications, warnings,
precautions, and adverse effects.
Instructions
To earn 1 hour of category 1 credit, read the material in this monograph carefully. Complete the activity evaluation and answer the post-test questions on the accompanying questionnaire. Follow the instructions on the post-test screens and your successful completion of this activity will be electronically submitted to Virginia Commonwealth University, Medical College of Virginia,
Office of Continuing Medical Education.
P.O. Box 980048, Richmond, VA 23298-0048.
Your credit certificate will be mailed to you. Participation is confidential. Estimated program completion time: 1 hour.
If you have any questions concerning your CME credits, please contact the OCME Registrar at 800/413-2872 or 804/828-5414.
Course Number: END 00 11 101 02
Release date: 12-01-02
Expiration date: 11-30-03
©Copyright 2001, Virginia Commonwealth University
Acknowledgement of Commercial Support
Supported by an unrestricted educational grant from Cephalon, Inc.
Listen to Real Audio Round Table Discussion
|
[Home]
|
|
